Related by context. All words. (Click for frequent words.) 76 TAXUS Express 74 TAXUS Express Stent 71 TAXUS ® 70 TAXUS Liberte Stent 69 TAXUS TM 68 paclitaxel eluting stent 68 PROMUS Element Stent 67 TAXUS Stent 66 TAXUS stent 66 TAXUS R 66 everolimus eluting stent 66 Taxus Stent 65 Coronary Stent 65 Cypher Stent 65 sirolimus eluting stent 65 XIENCE V PROMUS Stent 65 SYNERGY Stent 65 TAXUS Liberté stent 65 TAXUS Liberte stent 65 mm Stent 64 coronary stenting 64 Long Lesion 64 workhorse lesions 64 CYPHER R Sirolimus eluting 64 PROMUS Element Everolimus Eluting 64 NEVO ™ 64 Stent System 64 PROMUS 64 Atom Stent 64 PROMUS R 63 TAXUS 63 drug eluting stent DES 63 platinum chromium alloy 63 PROMUS Element 63 binary restenosis 62 Sirolimus eluting Coronary Stent 62 TAXUS V 62 thinner struts 62 TAXUS Liberte 62 R Paclitaxel Eluting 62 CYPHER ® Stent 62 NEVO TM 62 Coronary Stent System 62 recurrent GBM 62 diameter stenosis 62 XIENCE V Everolimus Eluting 62 TAXUS Express2 62 everolimus eluting stents 62 paclitaxel eluting stents 62 CYPHER R Stent 62 angiographic outcomes 62 sirolimus eluting stents 61 PROMUS TM 61 TAXUS Element 61 TAXUS Element Stent System 61 stent DES 61 transfemoral 61 paclitaxel eluting coronary stent 61 carotid stenting 61 zotarolimus eluting stent 61 SYNTAX trial 60 TAXUS Element Paclitaxel Eluting 60 TAXUS IV 60 PROMUS ® 60 failure TVF 60 Events MACE 60 Platinum Chromium 60 TAXUS Express2 Paclitaxel Eluting 60 Everolimus Eluting Coronary Stent 60 stent implantation 60 XIENCE V demonstrated 60 Endeavor drug eluting 60 zotarolimus 60 sirolimus eluting 60 ™ Everolimus Eluting 60 TAXUS Liberte Long 60 OPCAB 60 TAXUS Express Atom Stent 60 PressureWire 60 drug eluting coronary stent 60 Endeavor Resolute 59 Edwards SAPIEN valve 59 drug eluting coronary stents 59 Val HeFT 59 CANCIDAS 59 XIENCE 59 Combo Stent 59 carotid artery stenting 59 NAVISTAR R 59 target lesion revascularization 59 CYPHER Stent 59 TM Everolimus Eluting 59 definite stent thrombosis 59 CYPHER ® 59 prospectively stratified 59 Paclitaxel Eluting Coronary Stent 59 paclitaxel eluting 59 Resolute drug eluting 59 multivessel disease 59 Angiographic 59 Talent Abdominal Stent Graft 59 NEVO 59 XIENCE PRIME 59 CIMZIA ™ 59 TAXUS Liberte Atom Stent 59 TAXUS Liberte paclitaxel eluting 58 percutaneous intervention 58 active comparator 58 EverFlex 58 ARCOXIA 58 elective PCI 58 carotid artery stenting CAS 58 thrombus aspiration 58 TAXUS Liberté 58 IIIa inhibitor 58 Endeavor Drug Eluting 58 Express2 TM paclitaxel eluting 58 nonrandomized 58 Eluting Coronary Stent System 58 renal artery stenting 58 bypass graft CABG surgery 58 receiving prophylactic anticoagulation 58 TM Drug Eluting 58 Target Lesion Revascularization TLR 58 fully bioabsorbable 58 cardiac resynchronisation therapy 58 ABSORB trial 58 nonobstructive CAD 58 plus prednisone 58 Embolic Protection System 58 revascularizations 58 primary percutaneous coronary 58 patients undergoing percutaneous 58 carotid stent 58 Resolute DES 58 Pharmacokinetic parameters 58 Accelerated Partial Breast Irradiation 58 FFR guided 58 neointimal hyperplasia 57 MitraClip device 57 acute coronary syndromes ACS 57 de novo lesions 57 bivalirudin monotherapy 57 Liberte TM 57 coronary stent merged 57 nondiabetic patients 57 embolic protection device 57 coronary interventions 57 V Everolimus Eluting Coronary 57 Cypher Sirolimus 57 Drug eluting stent 57 sirolimus stent 57 MitraClip 57 CYPHER ® Sirolimus eluting 57 oral diclofenac 57 Custom NX R 57 fluvastatin 57 TM Paclitaxel Eluting 57 coronary revascularization 57 FOLFOX4 57 thrombus removal 57 plus gemcitabine 57 platinum chromium PROMUS 57 serum phosphorous 57 Acute Ischemic Stroke 57 dose pravastatin 57 CRT ICD 57 relapsing multiple sclerosis 57 oral Hycamtin 57 Sirolimus Eluting Coronary Stent 57 FFR guided treatment 57 GP IIb IIIa inhibitors 57 Myocardial Infarction Study 57 Edwards SAPIEN XT 57 coronary intervention 57 Express2 TM Paclitaxel Eluting 57 TAXUS VI 57 stenoses 57 MYDICAR ® 57 Soliris eculizumab 57 segment binary restenosis 57 XIENCE TM 57 TM paclitaxel eluting 57 Thrombolysis 57 Xience V 57 Self Expanding Stent 57 STRIDE PD 57 MULTI LINK VISION 56 primary patency 56 XIENCE V stent 56 undergoing coronary artery 56 IVUS imaging 56 bifurcation stent 56 Ceplene/IL-2 56 CRT Ds 56 acute myocardial infarction AMI 56 Coronary Artery Bypass Graft 56 MiStent DES 56 transcatheter aortic valve implantation 56 neoadjuvant 56 bioabsorbable stent 56 plaque excision 56 Major Adverse Cardiac 56 transthoracic 56 SpideRX 56 melphalan prednisone 56 TAVI 56 intracoronary 56 PASI scores 56 eluting coronary stent 56 cardiac perfusion 56 decitabine 56 carotid endarterectomy CEA 56 plus dexamethasone 56 ThromCat 56 Nitinol Stent 56 Cotavance 56 morphometric vertebral fractures 56 SPIRIT III 56 eluting stent 56 ENDEAVOR IV 56 chemotherapy gemcitabine 56 ABSORB 56 VELCADE melphalan 56 nicardipine 56 Xience Prime 56 XIENCE V vs. 56 Acute Myocardial Infarction 56 CABG surgeries 56 PERSEUS 56 demonstrated clinically meaningful 56 DEFINITY ® 56 RESOLUTE 56 Remote Magnetic Navigation 56 MERLIN TIMI 56 lymphadenectomy 56 Endeavor stent 56 metaglidasen 56 stage IIIb IV 56 GORE TAG Device 56 ACUITY trial 56 TAVR 56 events MACE 56 drug zotarolimus 56 LVEF 56 paclitaxel stent 56 CRESTOR #mg 56 Amrubicin 56 stent BMS 55 Plaque Excision System 55 Carotid Revascularization Endarterectomy vs. 55 CYPHER R Sirolimus Eluting 55 Emboli Capture Guidewire 55 Element Stent 55 unfractionated heparin UFH 55 rFVIIa 55 Stent thrombosis 55 LVAS 55 Embolic Protection Device 55 unstable angina UA 55 carboplatin paclitaxel 55 ARCALYST ® 55 defibrillator CRT D 55 cediranib 55 TLIF 55 Microwave Ablation System 55 Vascugel ® 55 unstable angina pectoris 55 revascularization procedures 55 WallFlex Biliary RX 55 mg BID dose 55 non valvular atrial 55 engineered anticoagulant 55 bypass grafting 55 MACCE 55 Novacor R 55 stent restenosis 55 Stabilimax NZ 55 infrapopliteal 55 preintervention 55 HeartMate R 55 bi ventricular pacing 55 Powerlink XL 55 Percutaneous Transluminal Coronary Angioplasty 55 vertebral compression fractures 55 STEMI ST 55 Taxus Liberté 55 revascularization 55 ARIXTRA 55 refractory angina 55 pharmacodynamic PD 55 Platinol ® cisplatin 55 SUPERA stent 55 Anti Bacterial Envelope 55 NYHA Class II 55 prospectively defined 55 graft patency 55 oncologic outcomes 55 Thalomid ® 55 STEMI patients 55 mcg QD 55 Eluting Stent 55 death dissection perforation 55 tipranavir r 55 concurrent chemoradiation 55 PressureWire Certus 55 anti arrhythmic drug 55 ICD implantation 55 HORIZONS AMI trial 55 undergoing percutaneous coronary 55 pharmacokinetic PK 55 composite endpoint 55 distal embolization thrombus formation 55 Tryton Side Branch 55 SPIRIT IV 55 Sirolimus eluting 55 PICSO ® 55 hemodynamically significant 55 L PPDS 55 paroxysmal AF 55 Emboshield 55 TACE 55 Turbo Tandem 55 stenting 55 Fractional Flow Reserve 55 Metricath Gemini 55 iodixanol 55 ATS 3f Aortic Bioprosthesis 55 TriActiv R 55 TAXUS drug eluting 55 RE LY 55 tenecteplase 55 Impella 55 Secca System 55 endoscopic remission 55 AngioSculpt Scoring Balloon Catheter 55 DU #b 55 Endeavor DES 55 CIMZIA TM 55 CIMZIA TM certolizumab pegol 55 gefitinib Iressa 55 MADIT II 55 QuadraSphere 55 PtCr 55 sustained virological response 55 Patency 55 chemoembolization 54 AneuRx 54 clevidipine 54 Randomized Evaluation 54 CABG surgery 54 cerebrovascular events 54 ACTEMRA TM 54 TAXUS p value 54 TAXUS Express2 paclitaxel eluting 54 VESTAsync 54 lumbar spine BMD 54 MEND CABG 54 myocardial infarction MI 54 HepaSphere 54 Stenting 54 transurethral resection 54 CD HORIZON 54 acute coronary syndromes 54 MGuard ™ 54 antithrombotic therapies 54 NovoTTF 54 Elitek 54 COR Analyzer 54 Taxus Element 54 irrigated catheter 54 catheter occlusion 54 angiographic restenosis 54 clinically localized prostate 54 CYPHER stent 54 pain palliation 54 relapsed refractory multiple myeloma 54 drug eluting stent 54 stable angina 54 multicenter clinical 54 OmniWave 54 ZoMaxx 54 Percutaneous Coronary Intervention 54 IV NSCLC 54 patients undergoing CABG 54 coronary lesions 54 CYPHER SELECT TM 54 coronary stenosis 54 Hycamtin ® 54 Dual Opioid 54 CLARITY study 54 FFR measurements 54 Hazard Ratio 54 restenotic lesions 54 Coronary artery bypass grafting 54 uncoated stent 54 Stenting Trial CREST 54 angiotensin receptor blocker ARB 54 atherothrombotic disease 54 Taxus Liberte stent 54 CYPHER R stent 54 refractory recurrent 54 Abbott XIENCE V 54 Endarterectomy 54 balloon expandable stent 54 postintervention 54 Operative mortality 54 LV dysfunction 54 GORE VIABAHN Endoprosthesis 54 Advanced Microspheres 54 biochemical recurrence 54 Coronary stent 54 PSADT 54 prospective randomized controlled 54 ICD therapy 54 failure ADHF 54 surgical aortic valve 54 SpyGlass System 54 neoadjuvant therapy 54 myocardial reperfusion 54 pegylated interferon alfa 2b 54 WallFlex 54 stented 54 Clinical Outcomes Utilizing Revascularization 54 InterStim Therapy 54 Tryton stent 54 prasugrel Effient 54 doxorubicin docetaxel 54 Balloon Kyphoplasty 54 XIENCE V 54 Acute Coronary Syndrome 54 cardiac resynchronization 54 placebo controlled clinical 54 transapical 54 Prospective Randomized Trial 54 cTnI 54 NAVISTAR ® THERMOCOOL ® 54 lipid lowering agents 54 CentriMag 54 EECP R 54 NeuroStar TMS Therapy 54 systemic embolism 54 eptifibatide 54 Flow Coupler 54 Paclitaxel Eluting Stent System 54 stent binary restenosis 54 ID TLR 54 trabectedin 54 TEVAR 54 oxycodone CR 54 FDG-PET/CT 54 percutaneous coronary interventions 54 Kaplan Meier analysis 54 TURBT 54 intravascular ultrasound IVUS 54 peripheral stent 54 echocardiographic parameters 54 bifurcated lesions 54 Abbott bioabsorbable everolimus eluting 54 reintervention 54 metastatic renal cell carcinoma 54 Octreolin 54 ischemic cardiomyopathy 54 periprocedural 54 prospective multicenter randomized 54 EuroSCORE 54 ARB telmisartan 54 everolimus eluting 54 null responder 54 ischemic complications 54 superficial femoral 54 BENICAR HCT 54 RE LY ® 54 alpha blocker 54 tirofiban 54 autologous chondrocyte implantation 54 ICD implants 54 Boston Scientific Taxus 53 KRAS mutations occur 53 descending thoracic 53 colorectal adenoma 53 TELIGEN 53 PRISTIQ 53 plus GP IIb 53 LATITUDE Patient Management 53 CABG 53 coronary stent implantation 53 vessel renarrowing 53 repeat revascularization 53 PROMUS Stent 53 TM Embolic Protection 53 Thal Dex 53 miRview meso 53 pegylated liposomal doxorubicin 53 drug eluting stents 53 F FDG PET 53 aortic insufficiency 53 Doxil ® 53 SYNTAX 53 HALO# [002] 53 TORISEL 53 PET myocardial perfusion 53 Balloon Catheter 53 Cordis Cypher 53 aldosterone antagonist 53 UA NSTEMI 53 Taxus Liberte 53 endovascular stent graft 53 multicenter prospective 53 Carotid 53 liposomal amphotericin B 53 Spectranetics laser 53 nadolol 53 tapentadol ER 53 noninferiority 53 liposomal doxorubicin 53 Endovascular System 53 Stretta 53 catheters guidewires 53 Custom NX 53 preventing restenosis 53 bivalirudin 53 Infarct 53 Drug Eluting Stents 53 pharmacodynamics PD 53 ischemia driven 53 NexStent 53 Cardiac Resynchronization Therapy 53 mRCC 53 lopinavir r arm 53 vorinostat 53 clot retrieval 53 VATS lobectomy 53 abluminal 53 Metricath 53 MoxDuo TM IR 53 aspirin heparin 53 virologic failure 53 ZACTIMA 53 low dose Iluvien 53 dacarbazine chemotherapy 53 Percutaneous Tibial Nerve Stimulation 53 CoreValve System 53 #beta estradiol 53 DES implantation 53 asymptomatic carotid stenosis 53 MULTI LINK 53 thiazolidinedione TZD 53 myocardial necrosis 53 dose dexamethasone 53 aspirin clopidogrel 53 Heparin Bioactive Surface 53 acute coronary syndrome 53 dose cytarabine 53 EchoCRT 53 sunitinib malate 53 angiotensin converting enzyme inhibitor 53 Lumbar Interbody Fusion 53 AngioSculpt 53 ReValving 53 levosimendan 53 Humalog ® 53 atherectomy 53 radiochemotherapy 53 octreotide LAR 53 thrombotic events 53 acute ischemic stroke 53 target vessel revascularization 53 TURBO Booster 53 TAXUS paclitaxel eluting coronary 53 thromboembolic events 53 renal artery stenosis 53 severe hypoglycemic 53 thrombolytic agents 53 antiarrhythmic drug 53 PD2i algorithm 53 pravastatin therapy 53 reinfarction 53 dose atorvastatin 53 Thrombectomy System 53 ATACAND 53 NSTE ACS 53 Bucindolol 53 tapentadol IR 53 Direct Visualization 53 BioSTAR R 53 IntraLase FS laser 53 recanalization 53 postoperative mortality 53 sipuleucel T 53 undergoing coronary angiography 53 Endurant 53 IVUS 53 percutaneous interventions 53 KRAS wild 53 AtherOx 53 mg clopidogrel 53 deep venous thromboses 53 oral antidiabetic medication 53 BioMatrix 53 pCR 53 severe aortic stenosis 53 teriflunomide 53 Bare Metal Stents 53 carotid stents 53 assessing T DM1 53 intravesical therapy 53 thrombectomy 53 antiangiogenic agent 53 gauge vitrectomy 53 secondary efficacy endpoint 53 Diovan HCT 53 transesophageal echocardiography 53 stent placement 53 GYN Surgical revenues 53 antiangiogenic therapy 53 GP IIb IIIa inhibitor 53 iliac artery disease 53 myocardial perfusion imaging 53 prespecified 53 VerifyNow P#Y# Test 53 CYPHER R 53 quantitative coronary angiography 53 TriActiv System 53 DAPT 53 haematologic 53 Drug Eluting Stent 53 clinicopathological features 53 AneuRx AAAdvantage 53 mechanical thrombectomy 53 radiosurgical 53 nab paclitaxel 53 carotid revascularization 53 Export Aspiration Catheter 53 somatostatin analog 53 anastomotic 53 dalteparin 53 adolescent idiopathic scoliosis 53 Ranibizumab 53 lispro 53 FFR measurement 53 intravascular imaging 53 death reinfarction 53 NPH insulin 53 VisuMax 53 certolizumab 53 locoregional 52 DuraHeart 52 epicardial 52 thromboembolic complications 52 Stent Thrombosis 52 receiving VICTRELIS 52 EBUS 52 peripheral vasculature 52 stents BMS 52 perioperative mortality 52 Drug Eluting Stent System 52 paclitaxel coated 52 PFO closure 52 liposomal formulation 52 TUMT 52 advanced adenomas 52 TTF Therapy 52 intravascular ultrasound 52 fibrinolytic therapy 52 vinorelbine 52 chemoradiotherapy 52 endovascular therapy 52 coronary drug eluting 52 stent thromboses 52 Penumbra System 52 ipsilateral stroke 52 Bivalirudin 52 pertuzumab 52 NATRECOR ® 52 TandemHeart System 52 Third Eye Retroscope 52 Sirolimus 52 vildagliptin 52 THERMOCOOL R 52 chronic angina 52 FOLFIRI 52 Reveal XT 52 X ray angiography 52 Warfarin Coumadin 52 antiplatelet therapy 52 IntuiTrak 52 noninferior 52 photocoagulation 52 standard chemotherapy regimen 52 surrogate endpoint 52 locoregional disease 52 intracerebral hemorrhage 52 circulating EPCs 52 anti restenotic 52 Free Survival PFS 52 MYLOTARG 52 depsipeptide 52 NYHA functional class 52 functional mitral regurgitation 52 transarterial 52 Acute Decompensated Heart Failure 52 Median survival 52 directed thrombolysis 52 Tarceva TM 52 COPERNICUS 52 Complication rates 52 MIST II 52 pulmonary capillary wedge 52 Taxus Express 52 serum phosphorus 52 intra aortic balloon 52 Catheter System 52 STARFlex R 52 recurrent VTE 52 HBeAg seroconversion 52 pamidronate 52 virologic response 52 Catheter ablation 52 cartilage lesions 52 Biolimus A9 52 IABP 52 symptomatic VTE 52 sorafenib Nexavar 52 deferiprone 52 sustained virologic response 52 baseline HbA1c 52 colorectal liver metastases 52 serum urate 52 ASTEROID 52 IFN alfa 52 cerebral somatic oximeter 52 decompensated heart failure 52 glycoprotein IIb IIIa inhibitor 52 replacement PAVR 52 HeartMate XVE 52 biochemical relapse 52 naïve HCV 52 Prospective Randomized 52 PREZISTA r arm 52 Myocardial Perfusion Imaging 52 TPV r 52 antithrombotic therapy 52 metastatic neuroendocrine tumors 52 ablation procedures 52 Stenting Trial 52 Epi LASIK 52 tumor lysis syndrome 52 undetectable HBV DNA 52 plus glycoprotein IIb 52 gemcitabine cisplatin 52 NMIBC 52 postoperative complication 52 BRIM2 52 conventional angiography 52 herpetic keratitis 52 HeartMate II 52 bioabsorbable drug eluting 52 STARFlex ® 52 ejection fractions 52 Edge STudy 52 angina myocardial infarction 52 percutaneous aortic valve 52 urethral bulking agent 52 #.#mg/dL 52 balloon kyphoplasty 52 somatostatin analogue 52 Masimo Rainbow SET Pulse 52 NYHA Class III 52 riociguat 52 radical cystectomy 52 antiplatelet agent 52 CNS LS 52 XGEVA 52 thromboembolism 52 Intravitreal 52 Vasomedical enhanced 52 Platinol ® 52 salmeterol fluticasone 52 RX ACCULINK Carotid Stent 52 mitral repair 52 CardioSEAL 52 cobalt chromium stent 52 MiniArc Precise 52 HES CEL 52 venous thromboembolic events 52 PTA balloon catheter 52 bioprostheses 52 aldosterone antagonists 52 MiniArc 52 VT VF 52 AGGRASTAT ® tirofiban hydrochloride 52 carotid stenosis 52 carotid stenting procedures 52 transarterial chemoembolization 52 pump CABG 52 Trevo System 52 CYPHER 52 alfuzosin 52 recurrent ischemic 52 embolic protection 52 IN.PACT 52 tumor progression TTP 52 vertebral fracture 52 CORDAPTIVE 52 efficacy evaluable 52 INTELLITEMP ® 52 MTWA testing 52 neoadjuvant chemotherapy 52 angiography CTA 52 anthracycline taxane 52 GORE TAG ® 52 echocardiographic 52 subgroup analyzes 52 StarClose 52 cobalt chromium 52 SilverHawk Plaque Excision System 52 endovascular procedures 52 pharmacokinetics PK 52 coronary anatomy 52 thienopyridine 52 breast brachytherapy 52 angiographically 52 Aggressive Drug Evaluation 52 EUS FNA 52 dacarbazine DTIC 52 rosuvastatin #mg 52 invasive coronary angiography 52 STENT 52 Endoscopic ultrasound 52 sunitinib Sutent 52 phase IIIb 52 Paclitaxel eluting 52 mycophenolate mofetil 52 MGuard 52 PSA kinetics 52 SVR# 52 Valdoxan 52 underwent resection 52 eptifibatide Injection 52 Cobalt Chromium 52 resected pancreatic cancer 52 saphenous vein graft 52 percutaneous transluminal coronary angioplasty 52 CryoMaze 52 metastatic malignant 52 thrombolytics 52 Bare Metal Stent 52 revascularization procedure 52 Nesiritide 52 endoleaks 52 VICTRELIS 52 Polyzene R F 51 hematuria abrupt 51 Angiox R 51 underwent percutaneous coronary 51 NSABP B 51 arterial thrombosis 51 PRECISE 51 Ischemic 51 lipid lowering drugs 51 PSA nadir 51 neo adjuvant 51 Crystalens AO 51 Temsirolimus 51 percutaneous coronary 51 evaluable subjects 51 Zometa hazard 51 Angio Seal Evolution 51 dipyridamole plus 51 MTWA 51 Kaplan Meier estimates 51 biologic DMARD 51 angiographic 51 ExTRACT TIMI 51 aneurysms AAA 51 ACR# response 51 bioresorbable polymer 51 atrial arrhythmias 51 Unified Parkinson Disease 51 ENDEAVOR clinical 51 cardiac resynchronization therapy 51 Pegylated Liposomal Doxorubicin 51 biliary stent 51 arterial thromboembolic events 51 fosbretabulin 51 Perceval S 51 inhospital mortality 51 ostial 51 FROVA 51 ribavirin RBV 51 CIPN 51 methotrexate monotherapy 51 cinacalcet 51 PlasmaBlade 51 MicroThermX 51 stratifying patients 51 RAPAFLO R 51 neoadjuvant treatment 51 CRp 51 RX ACCULINK 51 endarterectomy 51 fenofibrate 51 ReoPro 51 Erythropoietic therapies may 51 nonmetastatic prostate cancer 51 angioplasty stenting 51 ACCULINK 51 transthoracic echocardiography 51 metastatic RCC 51 Ablation System 51 interferon beta therapy 51 ADHF 51 Cardica Microcutter XPRESS 51 dacarbazine 51 VcMP 51 drug eluting balloon 51 multicentre randomized 51 ePTFE graft 51 Electronic Brachytherapy eBx 51 peginterferon alfa 2a 51 vein ablation 51 INEGY 51 + PH# 51 Transcatheter 51 Primary endpoints 51 Endoprosthesis 51 Carotid artery stenting 51 highest tertile 51 CorPath 51 liver resection 51 placebo dexamethasone 51 pimecrolimus 51 ST elevation myocardial 51 Perforomist ™ Inhalation Solution 51 locoregional recurrence 51 tolvaptan 51 femoral popliteal 51 Zilver PTX stent 51 vapreotide acetate 51 glycoprotein IIb IIIa inhibitors 51 Transurethral 51 thromboprophylaxis 51 self expanding nitinol 51 MitraClip R 51 intravenous diuretics 51 ImmuKnow assay 51 myocardial perfusion 51 remission CR 51 icatibant 51 infarct size 51 ezetimibe simvastatin 51 discontinuations due 51 percutaneous coronary intervention 51 VAPRISOL 51 Ventricular Assist Devices 51 electrophysiology procedures 51 Lenalidomide 51 troponin T 51 drug coated Taxus 51 receiving golimumab 51 Ascendra 51 carotid artery stent 51 myocardial infarctions 51 β blockers 51 myocardial infarction 51 paroxysmal atrial fibrillation 51 transcatheter 51 DAS# remission 51 ENDEAVOR III 51 Rubicon Filter 51 5-FU/LV 51 mcg albinterferon alfa 2b 51 penetrating keratoplasty 51 recurrent ischemia 51 Hypotension 51 rosuvastatin Crestor 51 debulking surgery 51 Nuclear Pharm Assist 51 DUROS 51 eplerenone 51 TIMP 1 51 symptomatic paroxysmal AF 51 punctal plug delivery 51 unfractionated heparin 51 segment elevation myocardial 51 IIIa inhibitors 51 Expanding Stent 51 nonischemic 51 PEGylated interferon 51 mid urethral sling 51 Hemodynamic 51 idraparinux 51 thromboembolic 51 intravascular 51 reslizumab 51 cangrelor 51 endovascular repair 51 bifurcation lesions